daunorubicin has been researched along with thiazolidines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, D; Roufogalis, BD | 1 |
| Geršl, V; Hašková, P; Jirkovský, E; Mertlíková-Kaiserová, H; Popelová, O; Simůnek, T; Stěrba, M; Vávrová, A | 1 |
| Almeida, DV; da Silva Nornberg, BF; de Oliveira, PV; Fagan, SB; González-Durruthy, M; Marins, LF; Marques, MB; Oliveira, BR | 1 |
3 other study(ies) available for daunorubicin and thiazolidines
| Article | Year |
|---|---|
Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation.
Topics: Actins; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Colchicine; Cycloheximide; Cytochalasin D; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endosomes; Green Fluorescent Proteins; Humans; Lysosomes; Microtubules; Protein Synthesis Inhibitors; Protein Transport; Recombinant Fusion Proteins; Thiazolidines | 2007 |
In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Buthionine Sulfoximine; Cell Line; Daunorubicin; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Heart; Heart Diseases; Hydrogen Peroxide; Male; Models, Animal; Oxidative Stress; Pyrrolidonecarboxylic Acid; Rabbits; Rats; Thiazolidines | 2011 |
Modeling drug-drug interactions of AZD1208 with Vincristine and Daunorubicin on ligand-extrusion binding TMD-domains of multidrug resistance P-glycoprotein (ABCB1).
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Binding Sites; Biphenyl Compounds; Cell Line, Tumor; Daunorubicin; Density Functional Theory; Drug Interactions; Humans; Ligands; Molecular Conformation; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Transport; Thiazolidines; Vincristine | 2019 |